Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
3′-Deoxy-3′-fluorothymidine is a nucleoside analog.1 It is phosphorylated by thymidine kinase 1 (TK1) but not TK2 and also inhibits TK1 and TK2 (Kis = 6 and 10 µM, respectively). 3′-Deoxy-3′-fluorothymidine inhibits HIV-1 reverse transcriptase (EC50 = 5 nM) and the replication of HIV-1 in MT-4 human T cell leukemia cells (EC50 = 5 nM).2 It decreases mitochondrial DNA (mtDNA) levels and the oxygen consumption rate (OCR) and induces upregulation of the cell differentiation marker CD11b in OCI-AML-2 and MV4-11 acute myeloid leukemia (AML) cells in a concentration-dependent manner.3 3′-Deoxy-3′-fluorothymidine (50 mg/kg) reduces tumor growth in an OCI-AML-2 AML mouse xenograft model. A radiolabeled form of 3′-deoxy-3′-fluorothymidine, [18F]FLT, is commonly used as a PET tracer for in vivo imaging of tumors.4
WARNING This product is not for human or veterinary use.
1. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. The Journal of Biological Chemisty 266(14), 9032-9038 (1991).
2. Comparisons of anti-
3. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia. Haematologica 104(5), 963-972 (2019).
4. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-